Bridgebio Pharma Inc (BBIO)

02:56 AM

What indicators show strength in BridgeBio Pharma Inc.Index Update & Reliable Price Breakout Alerts - newser.com

02:56 AM

01:30 AM

How buybacks impact BridgeBio Pharma Inc. stock valueVolume Spike & Real-Time Price Movement Reports - newser.com

01:30 AM

01:06 AM

Long term hold vs stop loss in BridgeBio Pharma Inc.July 2025 Sector Moves & Risk Managed Trade Strategies - newser.com

01:06 AM

12:36 PM

BridgeBio Pharma Inc. stock trend outlook and recovery path2025 Market Overview & Smart Investment Allocation Insights - newser.com

12:36 PM

Oct 12, 2025

Sentiment analysis tools applied to BridgeBio Pharma Inc.Weekly Trade Summary & Safe Entry Momentum Tips - newser.com

Oct 12, 2025

Oct 12, 2025

BridgeBio Pharma Hits New 52-Week High of $55.13, Up 94.83% - Markets Mojo

Oct 12, 2025

Oct 12, 2025

BridgeBio (BBIO) Leads Biotech Sector with Promising Pipeline - GuruFocus

Oct 12, 2025

Oct 12, 2025

SA Asks: What's the most attractive biotech stock right now? - Seeking Alpha

Oct 12, 2025

Oct 12, 2025

Oak Ridge Investments LLC Purchases New Holdings in BridgeBio Pharma, Inc. $BBIO - MarketBeat

Oct 12, 2025

Oct 12, 2025

Published on: 2025-10-12 03:32:49 - newser.com

Oct 12, 2025

Oct 11, 2025

BridgeBio Pharma (NASDAQ:BBIO) CEO Neil Kumar Sells 40,000 Shares - MarketBeat

Oct 11, 2025

Oct 10, 2025

Using flow based indicators on BridgeBio Pharma Inc.2025 Analyst Calls & Consistent Profit Trading Strategies - newser.com

Oct 10, 2025

Oct 10, 2025

Why BridgeBio Pharma Inc. (2CL) stock could outperform next yearJuly 2025 Breakouts & AI Based Trade Execution Alerts - newser.com

Oct 10, 2025

Oct 10, 2025

Will BridgeBio Pharma Inc. bounce back from current supportWeekly Risk Summary & Safe Entry Momentum Stock Tips - newser.com

Oct 10, 2025

Oct 09, 2025

BridgeBio Pharma (NASDAQ:BBIO) Given Sell (D-) Rating at Weiss Ratings - MarketBeat

Oct 09, 2025

Oct 09, 2025

BridgeBio Pharma Hits New 52-Week High of $55.33, Up 98.71% - Markets Mojo

Oct 09, 2025

Oct 09, 2025

Using economic indicators to assess BridgeBio Pharma Inc. potentialJuly 2025 Intraday Action & Daily Chart Pattern Signals - newser.com

Oct 09, 2025

Oct 09, 2025

Leading vs lagging indicators on BridgeBio Pharma Inc. performance2025 Momentum Check & Free Fast Entry Momentum Trade Alerts - newser.com

Oct 09, 2025

Oct 09, 2025

Real time breakdown of BridgeBio Pharma Inc. stock performanceIPO Watch & Risk Managed Investment Signals - newser.com

Oct 09, 2025

Oct 09, 2025

Will breakout in BridgeBio Pharma Inc. lead to full recoveryJuly 2025 Intraday Action & Growth Focused Entry Point Reports - newser.com

Oct 09, 2025

Oct 08, 2025

BridgeBio Pharma, Inc. Experiences Revision in Stock Evaluation Amid Strong Market Performance - Markets Mojo

Oct 08, 2025

Oct 08, 2025

BridgeBio Pharma Hits New 52-Week High of $54.64, Up 96.23% - Markets Mojo

Oct 08, 2025

Oct 06, 2025

BridgeBio Pharma (NASDAQ:BBIO) Sets New 12-Month HighHere's What Happened - MarketBeat

Oct 06, 2025

Oct 06, 2025

BridgeBio Pharma stock hits 52-week high at $54.61 By Investing.com - Investing.com South Africa

Oct 06, 2025

Oct 06, 2025

BridgeBio Pharma stock hits 52-week high at $54.61 - Investing.com

Oct 06, 2025

Oct 06, 2025

Analyzing drawdowns of BridgeBio Pharma Inc. with statistical toolsJuly 2025 Decliners & Fast Gaining Stock Strategy Reports - newser.com

Oct 06, 2025

Oct 06, 2025

BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(4) - MarketScreener

Oct 06, 2025

Oct 06, 2025

PFG Investments LLC Takes Position in BridgeBio Pharma, Inc. $BBIO - MarketBeat

Oct 06, 2025

Oct 06, 2025

What MACD and RSI say about BridgeBio Pharma Inc.Weekly Market Outlook & Target Return Focused Stock Picks - newser.com

Oct 06, 2025

Oct 05, 2025

Pattern recognition hints at BridgeBio Pharma Inc. upsideJuly 2025 EndofMonth & Pattern Based Trade Signal System - newser.com

Oct 05, 2025

Oct 04, 2025

BridgeBio Pharma (BBIO) Is Up 5.6% After Acoramidis Shows Broad ATTR-CM Benefit in Phase 3 Data - Yahoo

Oct 04, 2025

Oct 04, 2025

BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Oct 04, 2025

Oct 03, 2025

BridgeBio Pharma reports inducement grants under Nasdaq Listing Rule - MarketScreener

Oct 03, 2025

Oct 03, 2025

23,884 RSUs: BridgeBio Grants Inducement Shares with Quarterly Vesting Starting Nov. 16, 2026 - Stock Titan

Oct 03, 2025

Oct 03, 2025

What earnings revisions data tells us about BridgeBio Pharma Inc.2025 Geopolitical Influence & Daily Risk Controlled Trade Plans - newser.com

Oct 03, 2025

Oct 03, 2025

How big funds are accumulating BridgeBio Pharma Inc. (2CL) stockJuly 2025 Summary & Low Drawdown Trading Strategies - newser.com

Oct 03, 2025

Oct 02, 2025

UBS Reaffirms Buy on BridgeBio (BBIO) With Optimism Around Attruby Launch - Yahoo Finance

Oct 02, 2025

Oct 02, 2025

BridgeBio Pharma, Inc. (BBIO) Retains $68 Target on Strong Launch Dynamics - MSN

Oct 02, 2025

Oct 02, 2025

Platinum Investment Management Ltd. Grows Position in BridgeBio Pharma, Inc. $BBIO - MarketBeat

Oct 02, 2025

Oct 01, 2025

Hypoparathyroidism Market to Experience Notable Growth in Forecast Span by 2034, DelveInsight Predicts | Bridgebio/Calcil ytix Therapeutics, Ascendis Pharma, EnteraBio, Shire - Barchart.com

Oct 01, 2025